Literature DB >> 27117955

Calcitonin Gene-Related Peptide Downregulates Expression of Inducible Nitride Oxide Synthase and Caspase-3 after Intestinal Ischemia-Reperfusion Injury in Rats.

Chih-Cheng Luo1, Chen-Sheng Huang1, Yung-Ching Ming2, Shih-Ming Chu3, Hsun-Chin Chao4.   

Abstract

BACKGROUND: Various investigations have demonstrated that calcitonin gene-related peptide (CGRP) plays an important role in mediating ischemic preconditioning. CGRP has been shown to mimic the protective effects of ischemic preconditioning and mitigate ischemia-reperfusion (I/R) injury in the heart, brain, gastrointestinal system, and other tissues. This study aimed to examine whether CGRP, a proven intestinal cytoprotective molecule, exerted its protective effects through modulation of inducible nitride oxide synthase (iNOS) and apoptosis after intestinal I/R injury.
METHODS: This animal study randomly divided 30 rats into the following five groups: (1) the normal control group, (2) the ischemia group with normal saline, (3) the I/R group with normal saline, (4) the ischemia group with CGRP (300 μg/kg), and (5) the I/R group with CGRP (300 μg/kg). Levels of iNOS messenger RNA (mRNA) and protein, and caspase-3 protein were determined by real-time quantitative polymerase chain reaction and Western blotting analyses, respectively. Statistical analysis was performed using analysis of variance with Dunn test.
RESULTS: The mRNA levels of iNOS increased after the intestinal ischemia or intestinal reperfusion phase (p < 0.01), and CGRP pretreatment significantly decreased iNOS mRNAs and protein levels (p < 0.01). The expression protein levels of caspase-3 increased after the intestinal ischemia or intestinal reperfusion phase. CGRP pretreatment significantly decreased the levels of caspase-3 proteins. CGRP intestinal cytoprotection is mediated, in part, by downregulation of expression of iNOS and caspase-3 after intestinal I/R injury.
CONCLUSION: The study indicates that the cytoprotective role of CGRP (i.e., antiapoptotic effect) after I/R injury could be via downregulation of iNOS, which may relieve I/R tissue damage by blocking iNOS activity.
Copyright © 2016. Published by Elsevier B.V.

Entities:  

Keywords:  calcitonin gene-related peptide; caspase-3; inducible nitride oxide synthase; ischemia-reperfusion injury; small intestine

Mesh:

Substances:

Year:  2016        PMID: 27117955     DOI: 10.1016/j.pedneo.2015.10.012

Source DB:  PubMed          Journal:  Pediatr Neonatol        ISSN: 1875-9572            Impact factor:   2.083


  5 in total

1.  Calcitonin gene-related peptide has protective effect on brain injury induced by heat stroke in rats.

Authors:  Cheng-Xiang Lu; Ting Qiu; Zhi-Feng Liu; Lei Su; Biao Cheng
Journal:  Exp Ther Med       Date:  2017-09-18       Impact factor: 2.447

2.  Oxidative Stress Induces Chondrocyte Apoptosis through Caspase-Dependent and Caspase-Independent Mitochondrial Pathways and the Antioxidant Mechanism of Angelica Sinensis Polysaccharide.

Authors:  Chao Zhuang; Su Ni; Zhi-Cheng Yang; Rui-Ping Liu
Journal:  Oxid Med Cell Longev       Date:  2020-11-07       Impact factor: 6.543

3.  Protective effect of parecoxib sodium against ischemia reperfusion‑induced intestinal injury.

Authors:  Mei Li; Zhi Zheng
Journal:  Mol Med Rep       Date:  2021-09-09       Impact factor: 2.952

Review 4.  Alpha-Calcitonin Gene Related Peptide: New Therapeutic Strategies for the Treatment and Prevention of Cardiovascular Disease and Migraine.

Authors:  Ambrish Kumar; Maelee Williamson; Andrew Hess; Donald J DiPette; Jay D Potts
Journal:  Front Physiol       Date:  2022-02-11       Impact factor: 4.566

Review 5.  Translational Application of Fluorescent Molecular Probes for the Detection of Reactive Oxygen and Nitrogen Species Associated with Intestinal Reperfusion Injury.

Authors:  Gustavo Sampaio de Holanda; Samuel Dos Santos Valença; Amabile Maran Carra; Renata Cristina Lopes Lichtenberger; Bianca de Castilho; Olavo Borges Franco; João Alfredo de Moraes; Alberto Schanaider
Journal:  Metabolites       Date:  2021-11-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.